(53 days)
Not Found
No
The summary describes standard image processing and dose calculation for radiation therapy planning, without mentioning AI, ML, or related concepts.
No.
The device is a treatment planning system that helps prepare treatment plans for patients, but it does not directly apply or deliver therapy. Its function is to determine target locations, define beam locations, and visualize dose for radio surgery, which are pre-treatment planning activities.
No
The device is a treatment planning system used for preparing and calculating radiation doses for therapy, not for diagnosing diseases or conditions.
Yes
The device is described as "software" and its function is limited to processing images and planning treatment parameters. There is no mention of accompanying hardware or hardware components being part of the device itself.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the examination of specimens derived from the human body in order to provide information for diagnostic, monitoring, or compatibility purposes. This typically involves tests performed on blood, urine, tissue samples, etc.
- Device Function: The Explorer 4D™ Treatment Planning System software is used for treatment planning based on medical images (CT scans). It helps determine the location of the target, define treatment beams, and visualize dose distribution. It does not perform any tests on biological specimens.
- Intended Use: The intended use is clearly stated as "preparing treatment plans for patients who have intracranial diseases where neurological radio surgery has been prescribed." This is a therapeutic planning function, not a diagnostic one.
Therefore, the Explorer 4D™ Treatment Planning System falls under the category of a medical device used for treatment planning, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Explorer 4DTM Treatment Planning System software is intended for use in preparing treatment plans for patients who have intracranial diseases where neurological radio surgery has been prescribed.
The software is used to electronically import CT images to determine the precise location of the target, to define and visualize treatment beam locations, and to visualize dose to the target and other structures.
Product codes
MUJ
Device Description
The Explorer 4DTM Treatment Planning System (TPS) provides individual treatment plans for patients undergoing gamma radiation therapy treatment. The TPS provides for the import of patient images and selecting a series of relevant patient images to create a treatment plan.
Precise calculation of the dose delivery parameters is supported by the registration of fiducial markers as a reference point between patient images. These images are then annotated with the region of interest (ROI) to be exposed to radiation. Several tools are provided to adjust the ROI based on the desired treatment area, within these regions "shots" (radiation sources) and associated treatment dose levels are defined as they related to a specified collimator size.
When the plan definition is completed the operator can save or export the treatment plan.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
CT images
Anatomical Site
intracranial
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The Explorer 4D™ Treatment Planning System Performance Test Report (Attachment 10) provides data from ten separate performance tests demonstrating the dose delivery and spatial accuracy of the Explorer 4DTM Treatment Planning System.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Performance for both systems is spatial accuracy of 1 mm and accuracy of dose delivery is 3%.
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.5050 Medical charged-particle radiation therapy system.
(a)
Identification. A medical charged-particle radiation therapy system is a device that produces by acceleration high energy charged particles (e.g., electrons and protons) intended for use in radiation therapy. This generic type of device may include signal analysis and display equipment, patient and equipment supports, treatment planning computer programs, component parts, and accessories.(b)
Classification. Class II. When intended for use as a quality control system, the film dosimetry system (film scanning system) included as an accessory to the device described in paragraph (a) of this section, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
American Radiosurgery Explorer 4D104 Treatment Planning System Premarket Submission
AMERICAN RADIOSURGERY
JAN 1 1 2010
5. 510(k) Summary
| Submitter/Applicant Name: | American Radiosurgery, Inc. |
|---|---|
| Address: | 16776 Bernardo Center Drive, Suite 203 |
| San Diego, CA 92128 | |
| Phone number: | 858-451-6173 |
| Fax number: | 858-487-0662 |
| Contact: | John Clark |
| Contact person: | Dan Olivier (CCS, Inc.) |
| Phone number: | (858) 675-8200 |
| Fax number: | (858) 675-8201 |
| Date prepared: | October 30, 2009 |
| Trade name: | Explorer 4DTM Treatment Planning System |
| Common name: | Radiation Therapy Treatment Planning System |
| Classification name: | System, Planning, Radiation Therapy Treatment |
| Classification: | 21 CFR Part 892.5050 Class II |
Substantial equivalence claimed to:
The Explorer 4DTM Treatment Planning System is functionally and substantially equivalent to the Explorer 3D but hosted on a new hardware platform. Both systems include functionality for Dose Volume Histograms, visualization of dose shots, selection of skin boundary, phantom calibration, automated dose calculations, and the same collimator sizes. Performance for both systems is spatial accuracy of 1 mm and accuracy of dose delivery is 3%. New features in the Explorer 4D™ Treatment Planning System include automated skin boundary selection and an enhanced fiducial marker input and detection scheme.
Description
The Explorer 4D™ Treatment Planning System (TPS) provides individual treatment plans for patients undergoing gamma radiation therapy treatment. The TPS provides for the import of patient images and selecting a series of relevant patient images to create a treatment plan.
Precise calculation of the dose delivery parameters is supported by the registration of fiducial markers as a reference point between patient images. These images are then annotated with the region of interest (ROI) to be exposed to radiation. Several tools are provided to adjust the ROI based on the desired treatment area, within these regions "shots" (radiation sources) and associated treatment dose levels are defined as they related to a specified collimator size.
1
When the plan definition is completed the operator can save or export the treatment plan.
Performance
The Explorer 4D™ Treatment Planning System Performance Test Report (Attachment 10) provides data from ten separate performance tests demonstrating the dose delivery and spatial accuracy of the Explorer 4DTM Treatment Planning System.
Intended Use
The Explorer 4D™ Treatment Planning System software is intended for use in preparing treatment plans for patients who have intracranial diseases where neurological radio surgery has been prescribed.
The software is used to electronically import CT images to determine the precise location of the target, to define and visualize treatment beam locations, and to visualize dose to the target and other structures.
2
Image /page/2/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the department's name around the perimeter. Inside the circle is an abstract emblem featuring three stylized shapes that resemble birds in flight or flowing water. The emblem is a simple, bold design.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administfation 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
American Radiosurgery, Inc. % Mr. Daniel W. Lehtonen Responsible Third Party Official Intertek Testing Services 2307 E. Aurora Rd., Unit B7 TWINSBURG OH 44087
JAN 1 1 2010
Re: K093588
Trade/Device Name: Explorer 4D™ Treatment Planning System Regulation Number: 21 CFR 892:5050 Regulation Name: Medical Charged-particle radiation therapy system · Regulatory Class: II Product Code: MUJ Dated: December 29, 2009 Received: December 31, 2009
Dear Mr. Lehtonen:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA); You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
3
Page 2 .-
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Janine M. Morris
Janine M. Morris Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
4. Indications for Use
510(k) Number: _______________________________________________________________________________________________________________________________________________________________
Indications for Use:
The Explorer 4DTM Treatment Planning System software is intended for use in preparing treatment plans for patients who have intracranial diseases where neurological radio surgery has been prescribed.
The software is used to electronically import CT images to determine the precise location of the target, to define and visualize treatment beam locations, and to visualize dose to the target and other structures.
Prescription Use (Per 21 CFR 801 Subpart D) AND/OR
Over-the-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devices
510(k) Number.
Page 9 of 21